You're severely affected by MS if it restricts a lot how much you can move around. You'll also have a lot of MS symptoms at the same time. These won't go away and are complicated to deal with. Find out about symptoms and get resources to help you.
The Expanded Disability Status Scale (EDSS) is a way of measuring how much someone is affected by their MS. You might hear your neurologist talk about it or see it mentioned in reports on trials of MS drugs.
Disease modifying treatments (DMTs) may be able to reverse the symptoms caused by MS for some people with relapsing MS, according to new research published in the Journal of Neurology. This is the first study that has measured whether people’s long-term symptoms improve following treatment.
HSCT could have long-term benefits for some people with MS, according to the results of a large study that we co-funded. After five years, progression had stopped in just under half of the 239 people eligible for the treatment.
We’re proud to be co-funding the phase 3 trial to test if simvastatin could become a treatment for secondary progressive MS. This phase 3 trial will involve over 1000 people with secondary progressive MS. It begins in summer 2017 and will take six years to complete.
Findings from a UK survey show that during the early phase of the pandemic, when strict lockdown measures were taken, people with MS had a similar chance of getting coronavirus to the general population. The data reinforces that self-isolating greatly decreased the risk of coronavirus.